Legal status · Australia
Is B7-33 legal in Australia?
Written by Aaron CuhaReviewed Sep 2026
Direct answer
No. B7-33 is not an approved medicine in Australia. Its legal category is "Not approved; on Schedule 4 (a prescription-only list) or limited at import". Nothing that contains it is allowed for any use in people. Vials labeled "for research use only" get no exception: that label does not make them legal to use in people. On the evidence, no study in people is cited on its profile.
- People given it
- 0
- Found nothing
- 0
Legal category
Not approved; on Schedule 4 (a prescription-only list) or limited at import
TGA registration and the Poisons Standard schedule, from the B7-33 profile.
Reviewed Sep 2026. This is a legal category, not legal advice.
A "research use only" label on a vial does not make it legal to use on people.
B7-33 in Australia at a glance
| Legal category | Not approved; on Schedule 4 (a prescription-only list) or limited at import |
|---|---|
| TGA approval status | Not approved by TGA |
| Studies in people | 0 of 2 sources on the profile |
| Reviewed | Sep 2026 |
The legal category and note come from the B7-33 profile. We checked them against Therapeutic Goods Administration (TGA) listings on the reviewed date.
What this means
- 01
No product containing B7-33 is approved by TGA for any use in Australia. So nothing on sale is allowed for use in people.
- 02
"Research use only" is a label sellers put on. It is not a legal category that allows use in people, and it does not get a product out of medicines law.
- 03
Importing it, supplying it or promoting it for use in people can fall under medicines law in Australia. This page is general information, not legal advice.
What B7-33 is
B7-33 is a simpler, lab-made version of the hormone relaxin. It switches on relaxin's receptor in a way that leans toward fighting scar tissue. There are only animal and cell data.
Relaxin is a hormone that fights scar tissue, but it is hard to make. B7-33 was designed to get around that.
How it works: It switches on the relaxin receptor, RXFP1, in a way that favors the anti-scarring signal inside the cell.
Approval history: Not approved
How TGA treats this kind of product
Registers or lists medicines and health products on the ARTG, its official register. It also sorts substances into schedules in the Poisons Standard. Many peptides are Schedule 4 (prescription only). So having them without a prescription, or importing them for yourself, is restricted. That is true even when no product is registered.
The legal category above is how The Longevity Archive reads Therapeutic Goods Administration listings for B7-33 on the reviewed date. It is not a legal opinion. Rules change. Bringing a compound into the country, prescribing it and owning it can each be treated differently. Check with the agency before you act on anything here.
B7-33 in sport and the military
Whether B7-33 is banned in sport is set by the World Anti-Doping Code and by military rules, not by its legal status in Australia. Before you compete or get tested, look up B7-33 by name on the Prohibited List, or look up a named product in Global DRO. Under the World Anti-Doping Code, category S0 bans, at all times, any drug-like substance that meets two tests. No other section of the List covers it. And no government health regulator anywhere has a current approval for it as a treatment in people. Many substances that are approved somewhere are banned by name in another section. So approval does not mean a substance is allowed in sport.
- WADA Prohibited List
- Global DRO (check a named product)
- USADA (US athletes)
- Operation Supplement Safety (US service members)
The rules you compete or serve under decide this, not this page.
B7-33 in other countries
Frequently asked questions
Is B7-33 legal in Australia?
No. B7-33 is not an approved medicine in Australia. Its legal category is "Not approved; on Schedule 4 (a prescription-only list) or limited at import". Nothing that contains it is allowed for any use in people. Vials labeled "for research use only" get no exception: that label does not make them legal to use in people. On the evidence, no study in people is cited on its profile.
Can I buy B7-33 in Australia?
There is no approved product to buy. In Australia, B7-33 has the legal category "Not approved; on Schedule 4 (a prescription-only list) or limited at import". So no licensed pharmacy product exists. Sellers who list it "for research use only" are not selling it for use in people, and that label does not change its legal status. Sellers named on the price pages are ranked by certificate tier, then price, and any affiliate income is disclosed there. Naming a seller is not a recommendation to buy or use anything.
Is B7-33 TGA approved?
No. In Australia, B7-33 has the legal category "Not approved; on Schedule 4 (a prescription-only list) or limited at import". That is not a TGA approval to sell it. For comparison, its US FDA status is: Not approved. On the evidence, no study in people is cited on its profile.
Related compounds in Australia
Full research profile
How B7-33 works, the studies we cite, FDA status and the full legal summary are all on its compound profile.
B7-33 profileThis page is general information about the legal status of B7-33 in Australia, current as of Sep 2026. It is not legal advice. Legal status changes. For your own situation, check with Therapeutic Goods Administration or ask a lawyer. Educational use only. This database summarizes published research and is not medical advice. Where a dose appears it is a record of what a trial or clinic ran, or what people describe doing, with its source attached. Nothing here is a recommendation for personal use. Sellers named on the price pages are ranked by certificate tier, then price, and any affiliate income is disclosed there. Naming a seller is not a recommendation to buy or use anything.